ESMO26: Iza-bren leads post-TKI ADCs on efficacy, but toxicity could decide
On 26 October 2026, Li Zhang presented the Phase III PANKU-Lung01 trial at the European Society for Medical Oncology (ESMO)…
On 26 October 2026, Li Zhang presented the Phase III PANKU-Lung01 trial at the European Society for Medical Oncology (ESMO)…